One in five Britons don't know what a cataract or glaucoma is, poll finds
At least 10% of people will suffer age-related eye problems such as cataracts or glaucoma, but the survey of 2,000 Britons commissioned by the charity Guide Dogs shows a lack of awareness among the general public. (Source: the Mail online | Health)
Source: the Mail online | Health - June 25, 2022 Category: Consumer Health News Source Type: news

Janssen Presents Updated Data at EHA for Teclistamab in Patients with Relapsed or Refractory Multiple Myeloma
June 10, 2022 (VIENNA) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced updated efficacy and safety results from the teclistamab cohort of the Phase 1b TriMM-2 study (NCT04108195). Teclistamab, an investigational, off-the-shelf, T-cell redirecting bispecific antibody targeting B-cell maturation antigen (BCMA) is being studied in combination with DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) in patients with relapsed or refractory multiple myeloma (RRMM) who have received three or more prior lines of therapy.1 Patients in the study, including a high proportion with prior anti-CD38 exposur...
Source: Johnson and Johnson - June 10, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news

Janssen Presents Updated Results Evaluating First-in-Class GPRC5D Bispecific Antibody Talquetamab in Heavily Pretreated Patients with Multiple Myeloma
June 10, 2022 (VIENNA) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced updated results from the Phase 1 MonumenTAL-1 first-in-human dose-escalation study of talquetamab (NCT03399799), an investigational, off-the-shelf, T cell redirecting bispecific antibody targeting both GPRC5D, a novel multiple myeloma target, and CD3 on T cells.1 Results from the study showed encouraging responses in heavily pretreated patients with relapsed or refractory multiple myeloma (RRMM) who received talquetamab at the recommended subcutaneous Phase 2 dose (RP2D) administered weekly (QW) or every two weeks (Q2W).2 The...
Source: Johnson and Johnson - June 10, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news

Evidence Lacking for Glaucoma, Impaired Vision Screening Evidence Lacking for Glaucoma, Impaired Vision Screening
Task force calls for more research to determine value of screening in primary care.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 2, 2022 Category: Consumer Health News Tags: Ophthalmology News Source Type: news

Janssen to Highlight Science, Innovation and Advances in Robust Oncology Portfolio and Pipeline Through More Than 60 Data Presentations at ASCO and EHA
RARITAN, N.J., May 31, 2022 — The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that new research and data from its robust oncology portfolio and pipeline of investigational therapies will be presented at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place June 3-7 in Chicago, and the European Hematology Association (EHA) 2022 Congress taking place in Vienna, Austria, June 9-12. More than 60 presentations from company-sponsored studies across the two congresses, including 14 oral presentations, will feature new data and updates for both approved and investigation...
Source: Johnson and Johnson - May 31, 2022 Category: Pharmaceuticals Source Type: news

Glaucoma patient pathways guidance
The College of Optometrists and The Royal College of Ophthalmologists have developed guidance in response to the National Institute for Health and Care Excellence NG81 Glaucoma: diagnosis and management guidance to enable high-quality care for glaucoma patients, using the wide range of professional skills available. (Source: NHS Networks)
Source: NHS Networks - May 26, 2022 Category: UK Health Source Type: news

USPSTF: Evidence Lacking for Glaucoma Screening in Adults
TUESDAY, May 24, 2022 -- The U.S. Preventive Service Task Force (USPSTF) concludes that the evidence is currently insufficient to assess the balance of benefits and harms for screening for glaucoma in asymptomatic adults and for impaired visual... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 24, 2022 Category: Pharmaceuticals Source Type: news

The PreserFlo MicroShunt: A Conversation With Dr Ike Ahmed The PreserFlo MicroShunt: A Conversation With Dr Ike Ahmed
Dr Patel interviews Iqbal"Ike" K. Ahmed, MD, about the PreserFlo MicroShunt, an 8-mm-long tube that is inserted into the eye to help lower eye pressure in glaucoma.Medscape Ophthalmology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 19, 2022 Category: Consumer Health News Tags: Ophthalmology Viewpoint Source Type: news

Contact lens that can release drug could be used to treat glaucoma
Invention can deliver medication after detecting pressure in the eye from fluid buildup, scientists sayA contact lens that can release a drug if it detects high pressure within the eye has been created by scientists who say it could help treat glaucoma.Glaucoma is an eye disease that involves damage to the optic nerve, and can lead to blindness if not treated.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - May 17, 2022 Category: Science Authors: Nicola Davis Science correspondent Tags: Medical research Blindness and visual impairment Health Science Society World news Source Type: news

Self-reported  driving difficulty, avoidance, and negative emotion with on-road driving performance in older adults with glaucoma - Sabapathypillai SL, Perlmutter MS, Barco P, Wilson B, Gordon M, Carr D, Bhorade AM.
PURPOSE: To investigate the relationship between self-perceived driving difficulty, driving avoidance, and negative emotion about driving with glaucoma severity and on-road driving performance. DESIGN: Cohort Study METHODS: Glaucoma patients (n=111... (Source: SafetyLit)
Source: SafetyLit - May 5, 2022 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Eyesight: Cataracts, dry eye or glaucoma are among menopause warning signs in eyes
EYESIGHT is known to be affected when a woman enters the menopause. How can the condition affect a women's eyesight? (Source: Daily Express - Health)
Source: Daily Express - Health - April 29, 2022 Category: Consumer Health News Source Type: news

Bono health: U2 star always wears sunglasses due to decades-long glaucoma battle - signs
FOR OVER 20 years, Bono has worn tinted glasses everywhere - even indoors. But in the past, the star has explained the reason he wears them, and it's not for fashion. (Source: Daily Express - Health)
Source: Daily Express - Health - April 19, 2022 Category: Consumer Health News Source Type: news

Australian Researchers Develop a Superior Genetic Blood or Saliva Test for Detecting Glaucoma in High-risk Individuals
Should the test prove clinically viable, it could lead to new biomarkers for eye disease diagnostics and a new assay for clinical laboratories Scientists at Flinders University in Australia have developed a genetic blood or saliva test that, they say, is 15 times more effective at identifying individuals at high risk of glaucoma than current […] The post Australian Researchers Develop a Superior Genetic Blood or Saliva Test for Detecting Glaucoma in High-risk Individuals appeared first on Dark Daily. (Source: Dark Daily)
Source: Dark Daily - April 18, 2022 Category: Laboratory Medicine Authors: Jillia Schlingman Tags: International Laboratory News Laboratory Instruments & Laboratory Equipment Laboratory Pathology Laboratory Testing Molecular Diagnostics, Genetic Testing, Whole Gene Sequencing Precision Medicine anatomic pathology aqueous humour CDC ce Source Type: news

High blood pressure can put you at a greater risk of ‘irreversible blindness' - symptoms
APART from hiking your risk of medical emergencies, ranging from heart attacks to stroke, high blood pressure can also put you at a greater risk of glaucoma. What's worse, this eye condition is considered to be one of the "most common causes of irreversible blindness". Here are the warning signs to spot. (Source: Daily Express - Health)
Source: Daily Express - Health - April 12, 2022 Category: Consumer Health News Source Type: news

Eat fatty fish, walk more and take breaks to reverse eye damage caused by years of smoking
ACCUMULATIVE research shows that smoking significantly increases the risk of age-related macular degeneration, cataracts, glaucoma and dry eye syndrome. Aside from becoming a non-smoker, there are other ways to improve your sight. (Source: Daily Express - Health)
Source: Daily Express - Health - April 10, 2022 Category: Consumer Health News Source Type: news